Home » Global new crown cases approaching 250 million delta variants spread to ease-News-Science Net

Global new crown cases approaching 250 million delta variants spread to ease-News-Science Net

by admin


Global new crown cases approach 250 million delta variants, the spread has eased


China News Service, November 8th. According to a report by the US Chinese website, the number of confirmed cases of the new crown worldwide has approached 250 million on the 7th, and some countries in Eastern Europe are experiencing record outbreaks. At the same time, the surge of Delta virus variants has eased, and normal trade and tourism have gradually recovered.

According to Reuters analysis, the number of new cases in more than 50 countries around the world is still rising, and the new cases in Russia, Ukraine and Greece have reached or approached the record level since the beginning of the epidemic two years ago.

Eastern Europe has one of the lowest vaccination rates in Europe. According to analysis, more than half of all new infections reported globally are from European countries, and there are about 1 million new infections every four days.

Several regions in Russia have indicated that they may implement more restrictions or extend workplace lockdowns in response to the surge in cases.

According to Reuters analysis, in the past three months, the daily average number of cases has fallen by 36%. The analysis results show that although the spread of the virus has slowed down, 50 million people are infected every 90 days due to the spread of the highly contagious delta variant. Nearly a year after the initial start of the new crown epidemic, the number of confirmed cases only exceeded 50 million.

Health experts are optimistic that many countries have passed the worst of the epidemic due to vaccines and natural infections, but they warn that colder weather and upcoming holiday gatherings may increase the number of confirmed cases.

On the other hand, the United Kingdom has recently become the first country in the world to approve the new crown antiviral drug molnupiravir jointly developed by Merck and Ridgeback Biotherapy. Studies have shown that if the drug is taken in the early stages of the illness, it can reduce the chance of death or hospitalization by half for those who are most likely to develop severe cases.

According to Our World in Data statistics, more than half of the world‘s population has not yet been vaccinated. In low-income countries, less than 5% of people have received at least one dose of the vaccine.

The World Health Organization and other aid organizations called on the world’s 20 largest economies last monthleader, To provide funding for a US$23.4 billion plan to provide vaccines, tests and medicines to poorer countries in the next 12 months.

Special statement: The reprinting of this article is only for the purpose of disseminating information, and does not mean to represent the views of this website or to verify the authenticity of its content; if other media, websites or individuals reprint and use from this website, they must retain the information indicated on this website “Source”, and bear legal responsibility such as copyright; if the author does not want to be reprinted or contact reprinting fees and other matters, please contact us.

See also  The laser weapon revolution: that's why (even if the Russians don't have it) it's only a matter of time

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy